77 FR 71 pgs. 21998-21999 - Importer of Controlled Substances, Notice of Application, Lipomed, Inc.
Type: NOTICEVolume: 77Number: 71Pages: 21998 - 21999
FR document: [FR Doc. 2012-8763 Filed 4-11-12; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances, Notice of Application, Lipomed, Inc.
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on January 30, 2012, Lipomed, Inc., One Broadway, Cambridge, Massachusetts 02142, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances:
| Drug | Schedule |
|---|---|
| Cathinone (1235) | I |
| Methcathinone (1237) | I |
| 4-methyl-N-methylcathinone (1248) | I |
| N-Ethylamphetamine (1475) | I |
| N,N-Dimethylamphetamine (1480) | I |
| Fenethylline (1503) | I |
| Aminorex (1585) | I |
| 4-Methylaminorex (cis isomer) (1590) | I |
| Gamma Hydroxybutyric Acid (2010) | I |
| Methaqualone (2565) | I |
| Mecloqualone (2572) | I |
| 1-Pentyl-3-(1-naphthoyl)indole (7118) | I |
| 1-Butyl-3-(1-naphthoyl)-indole (7173) | I |
| 1-[2-(4-Morpholinyl)ethyl]-3-1(1-naphthoyl) indole (7200) | I |
| Alpha-ethyltryptamine (7249) | I |
| Ibogaine (7260) | I |
| 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- | |
| hydroxycyclohexyl]-phenol (7297) | I |
| 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3- | |
| hydroxycyclohexyl]-phenol (7298) | I |
| Lysergic acid diethylamide (7315) | I |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) | I |
| Marihuana (7360) | I |
| Tetrahydrocannabinols (7370) | I |
| Parahexyl (7374) | I |
| Nabilone (7379) | I |
| Mescaline (7381) | I |
| 3,4,5-Trimethoxyamphetamine (7390) | I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) | I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) | I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) | I |
| 2,5-Dimethoxyamphetamine (7396) | I |
| 2,5-Dimethoxy-4-ethylamphetamine (7399) | I |
| 3,4-Methylenedioxyamphetamine (7400) | I |
| 5-Methoxy-3,4-methylenedioxyamphetamine (7401) | I |
| N-Hydroxy-3,4-methylenedioxyamphetamine (7402) | I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) | I |
| 3,4-Methylenedioxymethamphetamine (7405) | I |
| 4-Methoxyamphetamine (7411) | I |
| 5-Methoxy-N-N-dimethyltryptamine (7431) | I |
| Alpha-methyltryptamine (7432) | I |
| Dimethyltryptamine (7435) | I |
| Psilocybin (7437) | I |
| Psilocyn (7438) | I |
| 5-Methoxy-N,N-diisopropyltryptamine (7439) | I |
| N-Ethyl-1-phenylcyclohexylamine (7455) | I |
| 1-(1-Phenylcyclohexyl)pyrrolidine (7458) | I |
| 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) | I |
| 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (7473) | I |
| N-Ethyl-3-piperidyl benzilate (7482) | I |
| N-Methyl-3-piperidyl benzilate (7484) | I |
| N-Benzylpiperazine (7493) | I |
| 3,4-methylenedioxypyrovalerone (7535) | I |
| 3,4-methylenedioxy-N-methylcathinone (7540) | I |
| Alphaprodine (9010) | I |
| Acetyldihydrocodeine (9051) | I |
| Benzylmorphine (9052) | I |
| Codeine-N-oxide (9053) | I |
| Cyprenorphine (9054) | I |
| Desomorphine (9055) | I |
| Etorphine (except HCl) (9056) | I |
| Etorphine HCl (9059) | I |
| Codeine methylbromide (9070) | I |
| Dihydromorphine (9145) | I |
| Difenoxin (9168) | I |
| Heroin (9200) | I |
| Hydromorphinol (9301) | I |
| Methyldesorphine (9302) | I |
| Methyldihydromorphine (9304) | I |
| Morphine methylbromide (9305) | I |
| Morphine methylsulfonate (9306) | I |
| Morphine-N-oxide (9307) | I |
| Myrophine (9308) | I |
| Nicocodeine (9309) | I |
| Nicomorphine (9312) | I |
| Normorphine (9313) | I |
| Pholcodine (9314) | I |
| Acetorphine (9319) | I |
| Acetylmethadol (9601) | I |
| Allylprodine (9602) | I |
| Alphacetylmethadol except levo-alphacetyl-methadol (9603) | I |
| Alphamethadol (9605) | I |
| Dioxaphetyl butyrate (9621) | I |
| Dipipanone (9622) | I |
| Ethylmethylthiambutene (9623) | I |
| Etonitazene (9624) | I |
| Etoxeridine (9625) | I |
| Furethidine (9626) | I |
| Hydroxypethidine (9627) | I |
| Ketobemidone (9628) | I |
| Levomoramide (9629) | I |
| Levophenacylmorphan (9631) | I |
| Morpheridine (9632) | I |
| Noracymethadol (9633) | I |
| Norlevorphanol (9634) | I |
| Normethadone (9635) | I |
| Norpipanone (9636) | I |
| Phenadoxone (9637) | I |
| Phenampromide (9638) | I |
| Phenoperidine (9641) | I |
| Piritramide (9642) | I |
| Proheptazine (9643) | I |
| Properidine (9644) | I |
| Racemoramide (9645) | I |
| Trimeperidine (9646) | I |
| Phenomorphan (9647) | I |
| Levo-alphacetylmethadol (9648) | I |
| Propiram (9649) | I |
| Tilidine (9750) | I |
| Para-Fluorofentanyl (9812) | I |
| 3-Methylfentanyl (9813) | I |
| Acetyl-alpha-methylfentanyl (9815) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Lisdexamfetamine (1205) | II |
| Phenmetrazine (1631) | II |
| Methylphenidate (1724) | II |
| Amobarbital (2125) | II |
| Pentobarbital (2270) | II |
| Secobarbital (2315) | II |
| Glutethimide (2550) | II |
| Nabilone (7379) | II |
| 1-Phenylcyclohexylamine (7460) | II |
| Phencyclidine (7471) | II |
| 4-Anilino-N-phenethyl-4-piperidine (8333) | II |
| Phenylacetone (8501) | II |
| Alphaprodine (9010) | II |
| Anileridine (9020) | II |
| Cocaine (9041) | II |
| Codeine (9050) | II |
| Dihydrocodeine (9120) | II |
| Oxycodone (9143) | II |
| Hydromorphone (9150) | II |
| Diphenoxylate (9170) | II |
| Benzoylecgonine (9180) | II |
| Ethylmorphine (9190) | II |
| Hydrocodone (9193) | II |
| Levomethorphan (9210) | II |
| Levorphanol (9220) | II |
| Isomethadone (9226) | II |
| Meperidine (9230) | II |
| Meperidine intermediate-B (9233) | II |
| Metazocine (9240) | II |
| Methadone (9250) | II |
| Methadone intermediate (9254) | II |
| Metopon (9260) | II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Dihydroetorphine (9334) | II |
| Levo-alphacetylmethadol (9648) | II |
| Oxymorphone (9652) | II |
| Noroxymorphone (9668) | II |
| Phenazocine (9715) | II |
| Piminodine (9730) | II |
| Racemethorphan (9732) | II |
| Racemorphan (9733) | II |
| Alfentanil (9737) | II |
| Remifentanil (9739) | II |
| Sufentanil (9740) | II |
| Carfentanil (9743) | II |
| Tapentadol (9780) | II |
| Bezitramide (9800) | II |
| Fentanyl (9801) | II |
The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes.
Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration, and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 1316.47.
Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than May 14, 2012.
This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745-46, all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: April 2, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2012-8763 Filed 4-11-12; 8:45 am]
BILLING CODE 4410-09-P